ScholarIQanswers from OpenAlex

Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection

PaperCitations, authors & open-access status

Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection have?

ScholarIQcitation count

Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection has 167 citations in the OpenAlex counts ScholarIQ stores.

When was Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection published?

ScholarIQyear

Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection has 2001 year in the ScholarIQ index.

What is the open-access status of Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection?

ScholarIQoa status

Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection has bronze oa status in the ScholarIQ index.

What is the DOI of Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection?

ScholarIQdoi

The DOI for Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection is on the source record.

What is the PMID of Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection?

ScholarIQpmid

The PMID for Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection is on the source record.

What is the OpenAlex record for Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection?

ScholarIQopenalex

The OpenAlex for Targeted deletion of CX3CR1 reveals a role for fractalkine in cardiac allograft rejection is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial